Creditable Coverage Disclosure to CMS OnLine Form and Instructions (CMS-10198)
Revision of a currently approved collection
No
Regular
02/12/2026
Requested
Previously Approved
36 Months From Approved
12/31/2028
134,351
141,400
11,152
11,784
0
0
Information collection requirements will ensure that entities that currently provide prescription drug benefits to any Medicare Part D eligible individual disclose to CMS whether the prescription drug benefit that they offer is creditable coverage. The disclosure is required to be provide annually and upon any change that affects whether the coverage is creditable prescription drug coverage. This collection also provides creditable coverage disclosure instructions for entities complying with these infromation collection request.
This iteration is associated with our November 28, 2025 (90 FR 54894) proposed rule (CMS-4212-P; RIN 0938-AV63). The rule estimates that about 5 percent of the 140,974 Group Health Plans (7,049 plans) will no longer be required to provide disclosure. In this regard we estimate a burden reduction of minus 7,049 responses, minus 632 hours, and minus $152,623.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.